Lawrence Lamb - Apr 27, 2025 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
EVP and CSO
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
Apr 27, 2025
Transactions value $
$0
Form type
4
Date filed
5/7/2025, 08:45 PM
Previous filing
Feb 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lamb Lawrence EVP and CSO C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK /s/ Jason Minio, Attorney-in-Fact 2025-05-07 0001830059

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series B Warrants (right to buy) Disposed to Issuer -1.64K -100% 0 Apr 27, 2025 Common Stock 1.64K $1.50 Direct F1, F2, F3
transaction INAB Series B Warrants (right to buy) Award +1.64K 1.64K Apr 27, 2025 Common Stock 1.64K $0.45 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.
F2 Fully vested and exercisable.
F3 The reported securities are included within 1,639 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 1,639 shares of common stock.